Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Equities
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.68 CNY | +0.30% |
|
+0.05% | -10.83% |
| Mar. 31 | Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Drops 4.4% in 2025 | MT |
| Mar. 31 | Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20% | MT |
Evolution of the Average Target: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Evolution of the Target Price: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Changes in Analyst Recommendations: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
d9e6b7f705af.SynZOakx9NuMv8QpuLXLX8qR4IMkPva8vBIxmlUDmcM.KUKRDPhdopDWxvVwy4WKBqnaqs9uToT69nVg9W133_sxWOpW4Eukus_Orw~abd2cecc41849ddef90b7d9a7309f3e5
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | - | |||
| +26.99% | |||||
| +34.39% | |||||
| +36.42% | |||||
| - | +27.25% | ||||
| - | - | - | |||
| +19.17% | |||||
| - | - | +28.07% | |||
| Average | +28.72% | |||||
| Weighted average by Cap. | +28.99% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
40.68
Average target price
-
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
40.68
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
- Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Select your edition
All financial news and data tailored to specific country editions
